These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 2332021)
1. Serum soluble CD8 antigen level is not elevated in mucocutaneous lymph node syndrome (Kawasaki disease) in spite of an increase in serum soluble interleukin 2 receptors. Furumoto H; Sakano T; Tanabe A; Hara M; Ida N Eur J Pediatr; 1990 Mar; 149(6):448-9. PubMed ID: 2332021 [No Abstract] [Full Text] [Related]
2. Serum-soluble interleukin-2 receptor levels in Kawasaki disease. Lang BA; Silverman ED; Laxer RM; Rose V; Nelson DL; Rubin LA J Pediatr; 1990 Apr; 116(4):592-6. PubMed ID: 2319407 [No Abstract] [Full Text] [Related]
3. Soluble CD30 serum antigen in Kawasaki disease. Vagliasindi C; Spinozzi F; Sensi L; Radicioni M; De Rosa O; Solinas L; Vaccaro R; Bertotto A Acta Paediatr; 1997 Mar; 86(3):317-8. PubMed ID: 9099324 [TBL] [Abstract][Full Text] [Related]
4. Soluble interleukin-2 receptors in children with Kawasaki syndrome. Barron KS; Montalvo JF; Joseph AK; Hilario MO; Saadeh C; Giannini EH; Orson FM Arthritis Rheum; 1990 Sep; 33(9):1371-7. PubMed ID: 1698369 [TBL] [Abstract][Full Text] [Related]
5. [Serum interleukin-2 receptor in patients with Kawasaki disease]. Matsubara T Arerugi; 1989 Jan; 38(1):49-56. PubMed ID: 2662945 [TBL] [Abstract][Full Text] [Related]
6. Immunoregulatory changes in Kawasaki disease. Jason J; Gregg L; Han A; Hu A; Inge KL; Eick A; Tham I; Campbell R Clin Immunol Immunopathol; 1997 Sep; 84(3):296-306. PubMed ID: 9281389 [TBL] [Abstract][Full Text] [Related]
7. Serum interleukin-6 in Kawasaki disease. Kim DS Yonsei Med J; 1992 Jun; 33(2):183-8. PubMed ID: 1413896 [TBL] [Abstract][Full Text] [Related]
8. Mononuclear cell subsets and coronary artery lesions in Kawasaki disease. Furukawa S; Matsubara T; Yabuta K Arch Dis Child; 1992 Jun; 67(6):706-8. PubMed ID: 1378258 [TBL] [Abstract][Full Text] [Related]
9. [Serum soluble CD4 and CD8 levels in Kawasaki disease]. Motohashi T Arerugi; 1992 Feb; 41(2 Pt 1):140-7. PubMed ID: 1567283 [TBL] [Abstract][Full Text] [Related]
10. The serum concentration of soluble interleukin-2 receptor in patients with Kawasaki disease. Teraura H; Kotani K; Minami T; Takeshima T; Shimooki O; Kajii E Ann Clin Biochem; 2017 Mar; 54(2):209-213. PubMed ID: 28081636 [TBL] [Abstract][Full Text] [Related]
11. Soluble CD2 levels in serum during acute Kawasaki disease and infectious mononucleosis. Furukawa S; Matsubara T; Obara T; Okumura K; Yabuta K J Infect Dis; 1993 Mar; 167(3):778-9. PubMed ID: 8095062 [No Abstract] [Full Text] [Related]
12. Increased serum interleukin-10 level in Kawasaki disease. Kim DS; Lee HK; Noh GW; Lee SI; Lee KY Yonsei Med J; 1996 Apr; 37(2):125-30. PubMed ID: 8711935 [TBL] [Abstract][Full Text] [Related]
13. [Expression of LFA-1 and ICAM-1 on peripheral blood T-cells and soluble CD2 levels in serum during acute Kawasaki disease]. Tsuji K Arerugi; 1993 Apr; 42(4):564-70. PubMed ID: 8323454 [TBL] [Abstract][Full Text] [Related]
14. The enhancement of anti-myosin antibody in mucocutaneous lymph node syndrome. Arimura A; Shimbo T Prog Clin Biol Res; 1987; 250():539-40. PubMed ID: 3423066 [No Abstract] [Full Text] [Related]
15. Recurrent mucocutaneous lymph node syndrome (Kawasaki disease): a report of three cases. Keren G; Passwell J; Cohen BE J Med; 1986; 17(5-6):365-71. PubMed ID: 3473170 [TBL] [Abstract][Full Text] [Related]
16. [Role of the B7/CD28 costimulatory molecules family in the pathogenesis of Kawasaki disease]. Ma YJ; Li YB; Yang J Zhonghua Er Ke Za Zhi; 2009 Mar; 47(3):220-1. PubMed ID: 19573439 [No Abstract] [Full Text] [Related]
17. The etiology of Kawasaki disease: superantigen or conventional antigen? Rowley AH Pediatr Infect Dis J; 1999 Jan; 18(1):69-70. PubMed ID: 9951986 [No Abstract] [Full Text] [Related]